---
title: "Metharbital - Epilepsy - 2"
sidebar: mydoc_sidebar
permalink: db00463-mesh-d004827-2.html
toc: false 
---


Path ID: `DB00463_MESH_D004827_2`
{% include image.html url="images/db00463-mesh-d004827-2.png" file="db00463-mesh-d004827-2.png" alt="db00463-mesh-d004827-2" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:C084822 | Metharbital | Drug |
| GO:0005245 | Voltage-gated calcium channel activity | BiologicalProcess |
| GO:0061535 | Glutamate secretion, neurotransmission | BiologicalProcess |
| MESH:D004827 | Epilepsy | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Metharbital | NEGATIVELY REGULATES | Voltage-Gated Calcium Channel Activity |
| Voltage-Gated Calcium Channel Activity | POSITIVELY REGULATES | Glutamate Secretion, Neurotransmission |
| Glutamate Secretion, Neurotransmission | POSITIVELY CORRELATED WITH | Epilepsy |
|---------|-----------|---------|

Comment: Withdrawn. This annotation is for higher concentrations of metharbital which can inhibit the calcium-dependent release of neurotransmitters such as glutamate.

Reference: 
  - [https://go.drugbank.com/drugs/DB00463](https://go.drugbank.com/drugs/DB00463)
  - [https://en.wikipedia.org/wiki/Barbiturate#Mechanism_of_action](https://en.wikipedia.org/wiki/Barbiturate#Mechanism_of_action)
